0000-0003-4867-1674 Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (15)
- Nano-curcumin promotes molecular interplay with PARP-1 and p53 proteins for therapeutic management of food-additive induced hyperglycemia in mice and L6 cells model: a molecular docking coupled experimental insight Save
- Design, synthesis and therapeutic exploration of nano-curcumin targeting the synergistic interactions with p53 and PARP-1 proteins in preventing food-additive induced genotoxicity and diabetic complications Save
- Unveiling the nano-particle enabled synergistic mitigation of the Bcl2/Cyt c/CYP1A1 signaling axis as a protective therapeutic route in mitochondrial dysfunction associated diabetes Save
- Morroniside interaction with poly (ADP-ribose) polymerase accentuates metabolic mitigation of alloxan-induced genotoxicity and hyperglycaemia: a molecular docking based in vitro and in vivo experimental therapeutic insight Save
- Novel PLGA-encapsulated-nanopiperine promotes synergistic interaction of p53/PARP-1/Hsp90 axis to combat ALX-induced-hyperglycemia Save
- Enhanced Drug Carriage Efficiency of Curcumin-Loaded PLGA Nanoparticles in Combating Diabetic Nephropathy via Mitigation of Renal Apoptosis Save
- Correction: Nano-pelargonidin modulates p53/PARP/HSP 90/XRCC1 signaling axis to combat cypermethrin-induced genotoxicity and metabolic dysfunction in fish: a molecular docking predicted in vivo approach Save
- Nano-phytocompound Combats Food Additive-Induced Genotoxicity and Mitochondrial Dysfunction in Diabetic Model: An In Silico Predicted Experimental Study Save
- Natural Inhibitors against Potential Targets of Cyclooxygenase, Lipoxygenase and Leukotrienes Save
- Poly lactide-co-glycolide encapsulated nano-curcumin promoting antagonistic interactions between HSP 90 and XRCC1 proteins to prevent cypermethrin-induced toxicity: An in silico predicted in vitro and in vivo approach Save